Breast Cancer: A Comprehensive Guide

What is Breast Cancer?

Breast cancer is a malignant tumor that develops in the cells of the breast tissue, most commonly in the milk ducts or lobules. It primarily affects women, though men can also develop the disease, accounting for approximately 1% of all breast cancer cases. Breast cancer is the second most common cancer in women worldwide and the leading cause of cancer death among women aged 20-59 years. With early detection and advances in treatment, survival rates have improved significantly, with five-year survival rates exceeding 90% when caught in early stages.

Key statistics

Symptoms

Common symptoms include: breast lump or thickening, breast pain, nipple discharge, breast skin changes, nipple retraction, swelling, dimpling.

Early symptoms:
– A new lump or mass in the breast or underarm area
– Thickening or swelling of part of the breast
– Irritation or dimpling of breast skin
– Redness or flaky skin in the nipple area or breast

Progressive symptoms:
– Clear or bloody discharge from the nipple
– Nipple retraction or inversion
– Change in breast size or shape
– Skin texture changes resembling orange peel (peau d’orange)

Submit Your Paper

Advanced symptoms:
– Bone pain (if cancer has spread to bones)
– Shortness of breath (if spread to lungs)
– Abdominal swelling (if spread to liver)
– Persistent fatigue and unexplained weight loss

Causes and risk factors

Breast cancer develops when normal breast cells undergo genetic mutations that cause them to grow and divide uncontrollably. While the exact cause is often unknown, several risk factors increase the likelihood of developing breast cancer.

Genetic factors:
– BRCA1 and BRCA2 gene mutations (hereditary breast cancer syndrome)
– Family history of breast or ovarian cancer
– Personal history of breast cancer
– Certain genetic syndromes (Li-Fraumeni, Cowden syndrome)

Hormonal factors:
– Early menstruation (before age 12) or late menopause (after age 55)
– Hormone replacement therapy
– Never having children or having first child after age 30
– Not breastfeeding

Lifestyle and environmental factors:
– Alcohol consumption
– Obesity, particularly after menopause
– Physical inactivity
– Radiation exposure to chest area
– Dense breast tissue

Prevention

While not all breast cancers can be prevented, several evidence-based strategies can reduce risk:

Screening recommendations:
– Annual mammograms starting at age 50 (earlier for high-risk individuals)
– Clinical breast exams every 1-3 years for women in their 20s and 30s
– Breast self-awareness and monthly self-examinations
– MRI screening for high-risk women (BRCA carriers)

Lifestyle modifications:
– Maintain healthy weight
– Exercise regularly (at least 150 minutes of moderate activity weekly)
– Limit alcohol consumption
– Breastfeed if possible
– Avoid unnecessary hormone therapy

High-risk interventions:
– Prophylactic mastectomy for BRCA mutation carriers
– Chemoprevention with tamoxifen or raloxifene for eligible high-risk women

Complications

Without treatment, breast cancer can spread (metastasize) to nearby lymph nodes and distant organs including bones, liver, lungs, and brain. Local complications include skin ulceration, chest wall invasion, and lymphedema. Metastatic breast cancer can cause bone fractures, breathing difficulties, liver dysfunction, and neurological symptoms. Even with treatment, patients may experience long-term complications such as lymphedema, peripheral neuropathy from chemotherapy, cardiac toxicity, and increased risk of secondary cancers. Treatment-related complications can include surgical complications, chemotherapy side effects, and radiation-induced skin changes or rare secondary malignancies.

Diagnosis

Breast cancer diagnosis involves multiple steps and tests:

Initial evaluation:
– Clinical breast examination
– Diagnostic mammography
– Breast ultrasound
– Breast MRI (in select cases)

Tissue confirmation:
– Core needle biopsy (preferred method)
– Fine needle aspiration (limited use)
– Surgical biopsy (rare)

Staging and molecular characterization:
– CT scans of chest, abdomen, and pelvis
– Bone scan or PET/CT scan
– Hormone receptor testing (estrogen and progesterone receptors)
– HER2/neu testing
– Multigene expression assays (Oncotype DX, MammaPrint)

Genetic testing:
– BRCA1/BRCA2 testing for eligible patients
– Comprehensive cancer gene panels for hereditary cancer syndromes

Treatment

Treatment approaches depend on cancer stage, molecular characteristics, and patient factors:

Surgery:
– Breast-conserving surgery (lumpectomy)
– Mastectomy (simple, modified radical, or radical)
– Sentinel lymph node biopsy
– Axillary lymph node dissection

Systemic therapy:
– Chemotherapy: doxorubicin, cyclophosphamide, paclitaxel, carboplatin
– Hormone therapy: tamoxifen, anastrozole, letrozole, fulvestrant
– Targeted therapy: trastuzumab, pertuzumab, palbociclib
– Immunotherapy: pembrolizumab (for triple-negative breast cancer)

Radiation therapy:
– External beam radiation therapy
– Accelerated partial breast irradiation
– Intraoperative radiation therapy

Prognosis

Breast cancer prognosis varies significantly based on stage at diagnosis, molecular subtype, and response to treatment. The overall five-year survival rate for all stages combined is approximately 91%. For localized breast cancer (confined to breast), five-year survival exceeds 99%. Regional spread (nearby lymph nodes) has an 86% five-year survival rate, while distant metastatic disease has a 29% five-year survival rate. Factors associated with better prognosis include smaller tumor size, absence of lymph node involvement, hormone receptor-positive status, and HER2-negative status. Triple-negative breast cancer generally has a more aggressive course but may respond well to chemotherapy and immunotherapy.

Quality of life

Living with breast cancer requires comprehensive support and lifestyle adjustments:

Physical considerations:
– Maintain regular exercise as tolerated (walking, swimming, yoga)
– Eat a balanced diet rich in fruits, vegetables, and lean proteins
– Stay hydrated and limit alcohol consumption
– Manage treatment-related fatigue with rest and gentle activity

Emotional support:
– Consider counseling or support groups
– Practice stress management techniques (meditation, mindfulness)
– Maintain social connections and communicate needs to family and friends
– Address body image concerns and intimacy issues

Practical management:
– Work with healthcare team to manage side effects
– Consider occupational therapy for lymphedema management
– Explore workplace accommodations during treatment
– Plan for follow-up care and survivorship needs

Survivorship care:
– Regular follow-up appointments and surveillance
– Bone health monitoring and supplementation
– Cardiovascular health assessment
– Secondary cancer screening

Pregnancy and fertility

Breast cancer during pregnancy occurs in approximately 1 in 3,000 pregnancies. Treatment decisions require multidisciplinary coordination between oncology and obstetric teams. Surgery can be safely performed during pregnancy, while chemotherapy may be considered in the second and third trimesters. Radiation therapy is typically delayed until after delivery. Cancer treatments can affect fertility through chemotherapy-induced ovarian dysfunction or surgical menopause. Fertility preservation options include embryo or egg freezing before treatment. Pregnancy after breast cancer treatment is generally safe for hormone receptor-negative cancers, though timing should be discussed with oncologists. Breastfeeding may be limited after breast surgery or radiation therapy.

Children

Breast cancer is extremely rare in children and adolescents. When it occurs in pediatric populations, it is often associated with genetic predisposition syndromes or previous radiation exposure. Most breast masses in children and adolescents are benign (fibroadenomas, cysts). Children of breast cancer patients may require genetic counseling and age-appropriate education about cancer and family history. Pediatric cancer centers provide specialized care when breast cancer occurs in young patients. Transition to adult care should begin in adolescence for those with genetic predisposition syndromes. School accommodations may be necessary if a child is undergoing treatment or has a parent with cancer.

When to see a doctor

Seek immediate medical attention for:
– New breast lump or mass
– Nipple discharge (especially bloody)
– Significant breast pain that persists
– Skin changes including redness, dimpling, or puckering
– Nipple retraction or inversion

Routine screening:
– Annual mammograms starting at age 50 (or earlier based on risk factors)
– Clinical breast exams as recommended by healthcare provider
– Genetic counseling if strong family history of breast/ovarian cancer

During treatment:
– Fever during chemotherapy
– Severe side effects from medications
– Signs of infection or delayed healing
– New concerning symptoms

Regional context

Breast cancer incidence varies across the Caucasus region, with Armenia reporting higher age-standardized incidence rates compared to Azerbaijan and Georgia. Limited data suggests later-stage diagnosis may be more common in some areas due to healthcare access challenges. Traditional dietary patterns in the Caucasus, rich in fruits, vegetables, and fermented dairy products, may offer some protective benefits. However, increasing urbanization and lifestyle changes may impact risk factors. GMJ welcomes contributions from regional researchers to build the evidence base for breast cancer prevention, treatment outcomes, and survivorship in the Caucasus.

Research and clinical trials

Current breast cancer research focuses on personalized medicine, immunotherapy combinations, and novel targeted therapies. Promising areas include antibody-drug conjugates, CDK4/6 inhibitors in various combinations, and liquid biopsies for monitoring treatment response. Research into triple-negative breast cancer treatments and prevention strategies for high-risk individuals continues to advance. Clinical trials are evaluating new combinations of existing drugs and novel agents targeting specific molecular pathways. Patients can search for clinical trials at ClinicalTrials.gov or through their cancer treatment centers. Participation in clinical trials may provide access to cutting-edge treatments while contributing to medical knowledge.

Frequently asked questions

Can men get breast cancer?

Yes, men can develop breast cancer, though it accounts for less than 1% of all breast cancer cases. Male breast cancer typically presents as a painless mass behind the nipple and often has a higher likelihood of being hormone receptor-positive.

Does wearing a bra cause breast cancer?

No scientific evidence supports the claim that wearing bras, including underwire bras, increases breast cancer risk. This is a common myth that has been thoroughly debunked by research studies.

If I have the BRCA gene mutation, will I definitely get breast cancer?

Having a BRCA1 or BRCA2 mutation significantly increases breast cancer risk (up to 70% lifetime risk), but it does not guarantee that cancer will develop. Many prevention and monitoring strategies can help reduce risk.

Can I drink alcohol if I’m a breast cancer survivor?

While moderate alcohol consumption may be acceptable for some survivors, alcohol does increase breast cancer risk and may affect treatment outcomes. Discuss individual recommendations with your oncologist.

How long do I need to take hormone therapy?

Hormone therapy duration varies based on individual factors, but typically ranges from 5-10 years for hormone receptor-positive breast cancer. Your oncologist will determine the optimal duration based on your specific situation and risk factors.

Support and resources

International organizations:
– World Health Organization Cancer Programme (www.who.int/cancer)
– American Cancer Society (www.cancer.org)
– Breast Cancer Research Foundation (www.bcrf.org)
– Susan G. Komen Foundation (www.komen.org)
– CancerCare (www.cancercare.org)
– National Cancer Institute (www.cancer.gov)

Patient advocacy groups:
– Young Survival Coalition (www.youngsurvival.org)
– Metastatic Breast Cancer Network (www.mbcn.org)
– Triple Negative Breast Cancer Foundation (www.tnbcfoundation.org)
– FORCE: Facing Our Risk of Cancer Empowered (www.facingourrisk.org)

Related conditions

– Ovarian Cancer – Often associated with BRCA mutations and hereditary cancer syndromes
– Ductal Carcinoma In Situ (DCIS) – Non-invasive breast cancer that may progress to invasive disease
– Lymphedema – Chronic swelling that can occur after breast cancer treatment
– Li-Fraumeni Syndrome – Hereditary cancer predisposition syndrome including breast cancer risk
– Atypical Hyperplasia – Benign breast condition that increases cancer risk

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.

Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.